Stay updated on Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page.

Latest updates to the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2; this change appears to be a minor technical update with no alteration to the study details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check24 days agoChange DetectedThe government funding/status notice has been removed from the page. Core study details, eligibility criteria, and contact/location information remain unchanged.SummaryDifference0.4%

- Check45 days agoChange DetectedCore study details such as interventions, eligibility criteria, primary outcome measures, enrollment, and locations appear unchanged between the screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check67 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference2%

- Check74 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%

- Check88 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed. No other substantive changes to core content, pricing, stock, or proper nouns.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page.